Such immunosuppression can occur in HCC progression where, particularly in the later stage, TGF-β facilitates cell invasion, angiogenesis, treatment resistance and transition of epithelial to mesenchymal cells [25]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.